TCIM
IMMU

TIAA CREF Investment Management’s Immunomedics Inc IMMU Stock Holding History

TIAA CREF Investment Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$5.22M Sell
271,929
-60,731
-18% -$979K ﹤0.01% 1414
2018
Q4 		$4.75M Buy
332,660
+53,429
+19% +$1.06M ﹤0.01% 1418
2018
Q3 		$5.82M Sell
279,231
-10,512
-4% -$249K ﹤0.01% 1471
2018
Q2 		$6.86M Buy
289,743
+38,540
+15% +$775K ﹤0.01% 1385
2018
Q1 		$3.67M Buy
251,203
+362
+0.1% +$5.92K ﹤0.01% 1761
2017
Q4 		$4.05M Sell
250,841
-21,534
-8% -$254K ﹤0.01% 1737
2017
Q3 		$3.81M Sell
272,375
-7,672
-3% -$76.5K ﹤0.01% 1790
2017
Q2 		$2.47M Buy
280,047
+14,261
+5% +$100K ﹤0.01% 2058
2017
Q1 		$1.72M Sell
265,786
-12,464
-4% -$63.1K ﹤0.01% 2223
2016
Q4 		$1.02M Sell
278,250
-106,424
-28% -$315K ﹤0.01% 2518
2016
Q3 		$1.25K Sell
384,674
-2,004
-0.5% -$5.6K ﹤0.01% 2423
2016
Q2 		$897K Sell
386,678
-52,978
-12% -$177K ﹤0.01% 2570
2016
Q1 		$1.1M Buy
439,656
+19
+0% +$43 ﹤0.01% 2419
2015
Q4 		$1.35M Sell
439,637
-1,046
-0.2% -$2.92K ﹤0.01% 2394
2015
Q3 		$758K Buy
440,683
+9,260
+2% +$23.6K ﹤0.01% 2730
2015
Q2 		$1.75M Buy
431,423
+33,359
+8% +$136K ﹤0.01% 2384
2015
Q1 		$1.52M Buy
398,064
+29,491
+8% +$128K ﹤0.01% 2390
2014
Q4 		$1.77M Sell
368,573
-2,551
-0.7% -$10.1K ﹤0.01% 2333
2014
Q3 		$1.38M Sell
371,124
-12,300
-3% -$41.6K ﹤0.01% 2453
2014
Q2 		$1.4M Buy
383,424
+22,623
+6% +$83K ﹤0.01% 2514
2014
Q1 		$1.52M Buy
360,801
+42,569
+13% +$211K ﹤0.01% 2398
2013
Q4 		$1.46M Buy
318,232
+20,207
+7% +$90K ﹤0.01% 2437
2013
Q3 		$1.84M Sell
298,025
-23,984
-7% -$138K ﹤0.01% 2257
2013
Q2 		$1.75M Buy
+322,009
New +$1.06M ﹤0.01% 2255

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

TIAA CREF Investment Management's IMMU Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Immunomedics Inc (IMMU) stake by 18% in Q1 2019, selling an estimated $979K and leaving 271,929 shares worth $5.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

TIAA CREF Investment Management first reported a position in IMMU in Q2 2013 and has held it in 24 quarters since. The position peaked at $6.86M in Q2 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q1 2019.

  • TIAA CREF Investment Management held 271,929 shares of Immunomedics Inc worth $5.22M as of Q1 2019.
  • TIAA CREF Investment Management sold 60,731 Immunomedics Inc shares in Q1 2019, an estimated $979K.
  • Immunomedics Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1414 holding.
  • TIAA CREF Investment Management first reported a position in Immunomedics Inc in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Immunomedics Inc position peaked at $6.86M in Q2 2018.
  • 204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.